Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New drug cocktail shows promise for Tough-to-Treat lymphoma

NCT ID NCT05364424

First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 23 times

Summary

This early-stage study tested a new drug, glofitamab, combined with standard chemotherapy (R-ICE) in 43 people with diffuse large B-cell lymphoma that returned or didn't respond to initial treatment. Participants were healthy enough to be candidates for a stem cell transplant or CAR-T cell therapy. The goal was to see if the combination could shrink tumors and how safe it was.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Chao Family Comprehensive Cancer Center UCI

    Orange, California, 92868, United States

  • Cleveland Clinic Foundation

    Cleveland, Ohio, 44195, United States

  • MD Anderson Cancer Center

    Houston, Texas, 77030, United States

  • Medical College of Wisconsin

    Milwaukee, Wisconsin, 53226, United States

  • Memorial Cancer Institute at Memorial West

    Pembroke Pines, Florida, 33028, United States

  • New York University Langone Medical Center

    New York, New York, 10016, United States

  • The University of Chicago

    Chicago, Illinois, 60637, United States

  • Tulane Medical Center

    New Orleans, Louisiana, 70112, United States

  • UMASS Memorial Medical Center

    Worcester, Massachusetts, 01655, United States

Conditions

Explore the condition pages connected to this study.